跳至主要内容
临床试验/TCTR20210123004
TCTR20210123004招募中2 期

Effect of melatonin on the reduction of oxidative stress and the prevention of contrast-induced acute kidney injury

Cardiac Electrophysiology Research and Training Center0 个研究点目标入组 40 人开始时间: 2021年1月23日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1. Age more than 18 years old
  • 2. Undergoing PCI
  • 3. CKD stage 3-5 (non-dialysis) with estimated glomerular filtration rate (eGFR) below than 60 mL/min/1.73 m2 measured by CKD-EPI method

排除标准

  • -ESRD on long term renal replacement therapy
  • -AKI with renal replacement therapy
  • -Receiving contrast media within 5 days
  • -Acute coronary syndrome within 5 days
  • -Acute decompensated heart failure
  • -Life-threatening cardiac arrhythmia (including ventricular tachycardia and ventricular fibrillation)
  • -Cardiac arrest
  • -Cardiogenic shock
  • -Sepsis or septic shock
  • -Active malignancy
  • -Volume of contrast in mL <3 times of eGFR
  • -Lupus nephritis
  • -Autosomal dominant polycystic kidney disease
  • -Severe anemia with hemoglobin <7 mg/dL
  • -Prior treatment with melatonin and other antioxidants; such as vitamin C, curcumin, and herbal medicine; in past 5 days

研究者

发起方
Cardiac Electrophysiology Research and Training Center

相似试验